Trial Information

Summary: A clinical study to test the safety and efficacy of an experimental drug in the treatment of stage II colon cancer patients following curative surgery

Long Island Jewish Medical Center is recruiting subjects with colon cancer who are expecting a surgical partial removal of the colon to participate in an experimental study. The study will determine the safety and efficacy of an experimental drug in preventing the recurrence of the cancer following surgical partial removal of the patient’s colon cancer.

You may be eligible to participate in this study if you:

• Are male or female at least 18 years of age
• Have confirmed stage II colon cancer

You may not participate in this study if you:

• Have stage I, III, or IV colon cancer
• Have evidence of residual cancer or cancer that has spread to other parts of the body
• Are pregnant or intend to become pregnant during the study
• Have any tumor originating in the rectum
• Have more than one malignant primary colon cancer
• Have a life expectancy of less than three years due to another condition
• Have any immune deficiency disease
• Have received prior chemotherapy, radiation therapy, or had another cancer (except certain skin and cervical cancers)
• Are undergoing systemic antibiotic therapy or have an acute infection within 5 days of study vaccination
• Have a history of chronic inflammation of the colon, Crohn’s disease, Gardner’s syndrome, or Turcot’s syndrome
• Have a history of tuberculosis; hepatitis B or C, or HIV
• Have cardiovascular or pulmonary complications or postoperative complications
• Have participated in another research study within the last 4 weeks prior to the start of this study

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.